NEOPHARM CO., LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 092730 for the last quarter is 26.15 B KRW, and it's 14.60% lower compared to the previous quarter. The net income of Q3 24 is 4.33 B KRW.